Do you have technical questions or need support for your Qognify installation?
Thanks to Cayuga ease of deployment, high scalability and customization abilities, Boehringer Ingelheim could significantly reduce deployment time for new CCTV instances, reducing overall project cost and time effort.
This also includes physical security applications – in particular the video management system (VMS). This variety of sites introduced a challenge for VMS system that could support end users with their requirements as well satisfy IT needs for stability and ease of support.
To find the right VMS that would meet all its current and future requirements, Boehringer Ingelheim conducted an in-depth vendor selection process, pitting the market-leaders in video management systems against each other and compare them with over 200 relevant questions from areas of IT security, system expandability and reliability of operation, as well as ease of deployment or expandability, followed by physical testing conducted by end users and technical team.
Out of the process Qognify’s VMS solutions has been selected as ideal for multi-site enterprise environments of Boehringer Ingelheim, with its focus on easy installation, configuration, and management. Supporting majority of network cameras available on the market, Cayuga manages all camera feeds to enable holistic video monitoring at a glance, whether centrally on-site or remotely, with ease.
Thanks to Cayuga ease of deployment, high scalability and customization abilities, Boehringer Ingelheim could significantly reduce deployment time for new CCTV instances, reducing overall project cost and time effort. In addition to that scalability and customization allows to sew system according to customers needs and improve their level of satisfaction from the solution.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.